BackgroundCheck.run
Search For

Bo O Peng, 593191 Aberdeen Way, Escondido, CA 92025

Bo Peng Phones & Addresses

3191 Aberdeen Way, Escondido, CA 92025   

22953 Oakgrove Rd, Sterling, VA 20166    703-4561881   

10300 Westlake Dr, Bethesda, MD 20817   

7316 Parkwood Ct APT 301, Falls Church, VA 22042    703-6560400   

Reston, VA   

Fairfax, VA   

Oakton, VA   

Education

School / High School: Emory University

Ranks

Licence: Georgia - Active Member in Good Standing Date: 2013

Mentions for Bo O Peng

Career records & work history

Lawyers & Attorneys

Bo Peng Photo 1

Bo Peng - Lawyer

Licenses:
Georgia - Active Member in Good Standing 2013
Education:
Emory University
Bo Peng Photo 2

Bo Peng - Lawyer

Specialties:
Business, Immigration, Real Estate, Wills-Trusts-Probate, Business, Real Estate, Wills-Trusts-Probate
ISLN:
1000226150
Admitted:
2015
University:
Vanderbilt University(M.L., 2013
Law School:
Vanderbilt University Law School, Master of Laws, 2013

Bo Peng resumes & CV records

Resumes

Bo Peng Photo 38

Bo Peng - Arlington, VA

Work:
CITIBANK COMPANY LIMITED Jan 2013 to Jul 2013
Branch Manager
Relationship Manager Mar 2009 to Dec 2012 Personal Banker Sep 2006 to Feb 2009 Top Performer 2006 to 2007
personal banker
Education:
BEIJING FOREIGN STUDIES UNIVERSITY Jun 2006
Bachelor of Arts in English
GEORGETOWN UNIVERSITY, McDonough School of Business - Washington, DC
Master of Business Administration
CHINA UNIVERSITY OF POLITICAL SCIENCE AND LAW
CFA in Finance Club
Bo Peng Photo 39

Bo Peng - Herndon, VA

Work:
Silver Diner - Merrifield, VA Jul 2011 to Oct 2013
Waiter

Publications & IP owners

Us Patents

Adenovirus Type7 Vectors

US Patent:
2004025, Dec 16, 2004
Filed:
Aug 5, 2004
Appl. No.:
10/487974
Inventors:
Xinli Nan - Bethesda MD, US
Bo Peng - Rockville MD, US
Tae-Wook Hahn - Kyeonggi-Do, KR
International Classification:
A61K048/00
C07H021/04
C12N007/00
C12N015/861
US Classification:
424/093200, 435/235100, 435/456000
Abstract:
The current invention provides novel adenovirus type 7 cosmid vectors for the production of adenovirus type 7 for use in gene transfer. In particular, the invention provides a replication-defective adenovirus type 7 that expresses one or more HIV polypeptides for use in stimulating an immune response to HIV-1.

Replication-Competent Adenoviral Vectors

US Patent:
2006011, Jun 1, 2006
Filed:
Nov 17, 2005
Appl. No.:
11/282319
Inventors:
Bo Peng - Rockville MD, US
Rebecca Voltan - Ferrara, IT
Barbara Ensoli - Rome, IT
Assignee:
The Government of the USA as represented by the Secretary of the Department of Health and Human - Rockville MD
Istituto Superiore de Sanita - Rome
International Classification:
A61K 48/00
C12N 15/861
C12N 15/867
US Classification:
424093200, 435456000
Abstract:
This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.

Cannabinoid Agonists

US Patent:
2013017, Jul 11, 2013
Filed:
Feb 9, 2011
Appl. No.:
13/578009
Inventors:
Jason Rohde - Rockville MD, US
Bo Peng - Arlington MA, US
Takashi Nakai - Newton MA, US
Kevin Sprott - Nedham MA, US
Wayne C. Schairer - Westboro MA, US
Galen John Carey - Stow MA, US
Assignee:
Ironwood Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 495/04
C07D 491/048
A61K 31/5377
A61K 31/437
A61K 31/4709
A61K 31/429
C07D 513/04
A61K 45/06
A61K 31/407
A61K 31/404
A61K 31/424
US Classification:
514171, 548454, 514414, 548453, 544143, 5142338, 546113, 514300, 514412, 548231, 514392, 514367, 548153, 514221, 546168, 514314, 435375
Abstract:
The present disclosure relates to compounds useful as agonists of the cannabinoid receptors. The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment of various disorders, either alone or in combination therapy. The compounds of the invention have Formula (I).

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.